Identification of multiple and distinct CD8+ T cell suppressor activities: Dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4476-4483

  Barker, Tobias D ^a,b   Weissman, Drew ^a,c   Daucher, James A ^a   Roche, Kim M ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HHMI Research Scholars Program

^c MSC 1576 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ARTICLE; CELL INTERACTION; DENDRITIC CELL; GAMMA IRRADIATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DENDRITIC CELLS; GAMMA RAYS; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; RADIATION TOLERANCE; SOLUBILITY; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY; VIRUS REPLICATION;

EID: 0029889608     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011.
2. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
3. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
4. Quinn, T. C. 1995. The epidemiology of the acquired immunodeficiency syndrome in the 1990s. Emer. Med. Clin. North Am. 13:1.
5. Riviere Y. 1994. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1. Cell. Mol. Biol. 40:45.
6. Kalams, S. A., and B. D. Walker. 1994. The cytotoxic T-lymphocyte response in HIV-1 infection. Clin. Lab. Med. 14:271.
7. Walker, B. D., and F. Plata. 1990. Cytotoxic T lymphocytes against HIV. AIDS 4:177.
8. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345.
9. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563.
10. + cells involves a noncytotoxic mechanism. J. Virol. 65:5921.
11. + T cells. Evidence for a soluble inhibitor. J. Immunol. 144:2961.
12. + T lymphocytes suppresses HIV replication. Immunology 66:628.
13. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses 8:1039.
14. + cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159:271.
15. + T cells correlates with CD4 counts and clinical stage of disease. Clin. Exp. Immunol. 97:68.
16. + cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87:1462.
17. + cells varies among infected individuals. Cell. Immunol. 119:470.
18. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106.
19. + cell antiviral factor. Cell. Immunol. 153:329.
20. + cells from HIV-I infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell. Immunol. 137: 420.
21. + cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159:271.
22. + cells from infected and uninfected chimpanzees. Cell. Immunol. 132:246.
23. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92:2308.
24. + T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res. Hum. Retroviruses 9:1079.
25. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
26. Weissman, D., Y. Li, J. M. Orenstein, and A. S. Fauci. 1995. Both a precursor and a mature population of dendritic cells can bind HIV; however, only the mature population that expresses CD80 can pass infection to unstimulated CD4 positive T cells. J. Immunol. 155:4111.
27. Weissman, D., Y. Li, J. Ananworanich, L-J. Zhou, J. Adelsberger, T. F. Tedder, M. Baseler, and A. S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:826.
28. Karhumaki, E., M. E. Viljanen, M. Cottler-Fox, A. Ranki, C. H. Fox, and K. J. Krohn. 1993. An improved enrichment method for functionally competent, highly purified peripheral blood dendritic cells and its application to HIV-infected blood samples. Clin. Exp. Immunol. 91:482.
29. + T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 95:436.
30. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquired Immune Defic. Syndr. 6:904.
31. Kestens, L., G. Vanham, P. Gigase, G. Young, I. Hannet, F. Vanlangendonck, F. Hulstaert, and B. A. Bach, 1992. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 6:793.
32. Bogner, J. R., and F. D. Goebel. 1991. Lymphocyte subsets as surrogate markers in antiretroviral therapy. Infection 19:S103.
33. Palayoor, S. T., R. M. Macklis, E. A. Bump, and C. N. Coleman. 1995. Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat. Res. 141:235.
34. + T-cells. Science 270:1811.
35. Baier, M., A. Werner, N. Bannert, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.